抗寄生虫的
抗寄生虫药
生物
克鲁兹锥虫
无鞭毛体
体外
抗氧化剂
药理学
杀虫药
利什曼原虫
噻唑
体外毒理学
生物利用度
谷胱甘肽
生物化学
化学
立体化学
酶
寄生虫寄主
病理
万维网
医学
计算机科学
作者
Natali de França Nibbering Santos,Natanael da Silva Bezerra,Jamerson Ferreira de Oliveira,Denise Duarte,José Cleberson dos Santos Soares,Diego Santa Clara Marques,Aline Caroline da Silva Santos,Fátima Nogueira,Valéria Rêgo Alves Pereira,Maria Carmo Alves de Lima,Iranildo José da Cruz Filho
标识
DOI:10.1016/j.exppara.2023.108498
摘要
In this work, 13 thiosemicarbazones (1a – m) and 16 thiazoles (2a – p) were obtained, which were properly characterized by spectroscopic and spectrometric techniques. The pharmacokinetic properties obtained in silico revealed that the derivatives are in accordance with the parameters established by lipinski and veber, showing that such compounds have good bioavailability or permeability when administered orally. In assays of antioxidant activity, thiosemicarbazones showed moderate to high antioxidant potential when compared to thiazoles. In addition, they were able to interact with albumin and DNA. Screening assays to assess the toxicity of compounds to mammalian cells revealed that thiosemicarbazones were less toxic when compared to thiazoles. In relation to in vitro antiparasitic activity, thiosemicarbazones and thiazoles showed cytotoxic potential against the parasites Leishmania amazonensis and Trypanosoma cruzi. Among the compounds, 1b, 1j and 2l stood out, showing inhibition potential for the amastigote forms of the two parasites. As for the in vitro antimalarial activity, thiosemicarbazones did not inhibit Plasmodium falciparum growth. In contrast, thiazoles promoted growth inhibition. This study shows in a preliminary way that the synthesized compounds have antiparasitic potential in vitro.
科研通智能强力驱动
Strongly Powered by AbleSci AI